Edition:
United Kingdom

Moleculin Announces Polish Approval For Leukemia Clinical Trial


Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Moleculin Biotech Inc ::MOLECULIN ANNOUNCES POLISH APPROVAL FOR LEUKEMIA CLINICAL TRIAL.MOLECULIN BIOTECH - ETHICS COMMITTEE IN POLAND HAS APPROVED COMPANY'S PHASE I/II CLINICAL TRIAL OF ANNAMYCIN FOR TREATMENT OF LEUKEMIA.MOLECULIN BIOTECH INC - COMPANY EXPECTS FIRST PATIENT TO BE ENROLLED IN Q1 2018.MOLECULIN BIOTECH - BELIEVES CLINICAL DATA PRODUCED IN POLAND WILL BE USEFUL IN INTERACTIONS WITH U.S. FDA, EUROPEAN MEDICINES AGENCY.